Test Background β2-glycoprotein 1 is a co-factor for anticardiolipin antibodies. Anti-β2-glycoprotein antibodies (IgG and IgM) are seen in antiphospholipid syndrome and can be related to the development of arterial and venous thromboses, venous thromboembolism, thrombocytopenia and fetal loss.
Clinical Indications Diagnosis and monitoring of: vascular thrombosis and/or recurrent fetal loss thrombocytopenia heart valve disease nephropathy neurological disease.
< 20 GPL-U/mL and < 20 MPL U/mL
Sample Required RST (rust top)
Sample Volume 5-10 mL (1 mL serum)
Turnaround Time 7 days.
Notes This test is currently unaccredited due to a recent change in platform/assay.